Navigation Links
Merrimack Pharmaceuticals To Present Phase I Data On MM-302 And Preclinical Data On Companion Diagnostics Both For The Treatment Of HER2-Positive Breast Cancer
Date:11/27/2012

" type="square">
  • Friday, December 7, 2012
  • 7:00 - 9:00 a.m. CT, Exhibit Hall A-B
  • Quantification of HER2 Expression at the Single Cell Level and HER2 Intratumoral Heterogeneity of Breast Cancer Tissue Samples Using Automated Image Analysis (Abstract #: P1-07-03)
    • Poster Session 1: Prognostic and Predictive Factors – Biomarkers, Methods
      • Wednesday, December 5, 2012
      • 5:00 – 7:00 p.m. CT, Exhibit Hall A-B
  • About Merrimack Pharmaceuticals, Inc.
    Merrimack Pharmaceuticals is a biopharmaceutical company discovering, developing and preparing to commercialize innovative medicines paired with companion diagnostics for the treatment of serious diseases, with an initial focus on cancer. Merrimack applies Network Biology, its proprietary systems biology-based approach to biomedical research, throughout the research and development process. Merrimack currently has five targeted therapeutic oncology candidates in clinical development.

    Forward-Looking Statement
    Any statements in this press release about future expectations, plans and prospects for Merrimack constitute forward-looking statements within the meaning of The Private Securities Litigation Reform Act of 1995, as amended. Actual results may differ materially from those indicated by such forward-looking statements. Merrimack anticipates that subsequent events and developments will cause its views to change. However, while Merrimack may elect to update these forward-looking statements at some point in the future, Merrimack specifically disclaims any obligation to do so.


    '/>"/>
    SOURCE Merrimack Pharmaceuticals, Inc.
    Copyright©2012 PR Newswire.
    All rights reserved

    Page: 1 2

    Related medicine technology :

    1. Avanir Pharmaceuticals Pre-Announces Preliminary Fiscal 2012 Fourth Quarter Results And Provides Clinical Study Update
    2. Unigene and Tarix Pharmaceuticals Enter Definitive Licensing Agreement for "Peptelligence-Engineered" TXA127
    3. Actinium Pharmaceuticals Sponsors Webinar on Clinical Use of Alpha Immunotherapy
    4. Edison Pharmaceuticals Closes $20M Series F Financing
    5. Valeant Pharmaceuticals Announces Publication of Efinaconazole Phase III Results
    6. Zacks Sell List Highlights: J.C. Penney, Spirit AeroSystems Holdings, The New York Times and Jazz Pharmaceuticals
    7. Cadence Pharmaceuticals CEO Ted Schroeder To Present At The Piper Jaffray 24th Annual Healthcare Conference In New York City On November 28, 2012
    8. Avanir Pharmaceuticals To Present At 24th Annual Piper Jaffray Healthcare Conference
    9. Arena Pharmaceuticals to Webcast Live Presentation at the Piper Jaffray 24th Annual Healthcare Conference
    10. AcelRx Pharmaceuticals to Present at the Piper Jaffray 24th Annual Healthcare Conference
    11. Anthera Pharmaceuticals to Present at the Piper Jaffray Health Care Conference
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:7/22/2014)... Research and Markets has announced the addition ... Reagent, by Application - Global Forecast to 2018" ... http://photos.prnewswire.com/prnh/20130307/600769 Biopharmaceuticals are pharmaceutical products isolated ... most important and widely used techniques for biopharmaceutical production. ... cell culture market in 2013. Growth in the biopharmaceutical ...
    (Date:7/22/2014)... According to a new ... (Technology Types - Near infrared (NIR) spectroscopy, Raman spectroscopy and ... Size, Share, Growth, Trends and Forecast, 2013 - 2019," the ... is expected to grow at a CAGR of 7.4% from ... was the largest contributor to global process spectroscopy market ...
    (Date:7/22/2014)... 2014 BiologicTx ® today announced their ... Kidney Paired Donation transplant exchange utilizing BiologicTx,s proprietary matching ... 9 at the Miami Transplant Institute, located at Jackson ... Kidney Paired Donation (KPD) is an ... kidney transplant with one another due to incompatible blood ...
    Breaking Medicine Technology:Global Cell Culture (Bioreactor, Incubator, Centrifuge) Market - Forecast to 2018 2Global Cell Culture (Bioreactor, Incubator, Centrifuge) Market - Forecast to 2018 3Process Spectroscopy Market Expected to Reach USD 1,179.6 Million in 2019: Transparency Market Research 2Process Spectroscopy Market Expected to Reach USD 1,179.6 Million in 2019: Transparency Market Research 3Process Spectroscopy Market Expected to Reach USD 1,179.6 Million in 2019: Transparency Market Research 4BiologicTx Paired Donation Aids In Successful Kidney Transplants 2BiologicTx Paired Donation Aids In Successful Kidney Transplants 3
    ... July 12, 2011 Sevocity, the leader in ... v11.1 has achieved full certification through the Certification ... a CCHIT Certified® 2011 Ambulatory EHR.  Sevocity v11.1 ... the highest level awarded by CCHIT.  The Certification ...
    ... 12, 2011 ,   ... are,pleased to announce that they have been engaged ... apricitabine (ATC), a late-stage,novel treatment for HIV infection. ... the,healthcare and investment business sectors. Dr ...
    Cached Medicine Technology:Sevocity Division of Conceptual MindWorks Inc.'s Sevocity EHR Earns CCHIT 2011 Certification 2PharmaVentures Engaged by Avexa to Assist in the Out-licensing of Apricitabine 2
    (Date:7/22/2014)... Los Angeles, CA (PRWEB) July 22, 2014 ... leads the way in providing resources, educational tools and ... that tell the stories of prevention, treatment and recovery. ... drama BLACK BOX will spotlight some of these resources ... Mental Health Services Administration helpline and treatment website at ...
    (Date:7/22/2014)... The market for botulinum neurotoxin (BoNT) products has ... novel medical indications created and due to more cosmetic ... physical appearance is extremely valued. Although the BoNT market ... companies and technologies are setting ground for biosuperiors and ... price of 1st-gen products under pressure, only innovation is ...
    (Date:7/22/2014)... Doheny HealthDay Reporter TUESDAY, ... a minimally invasive procedure known as morcellation carries a risk ... the likelihood more clearly. Twenty-seven of every 10,000 women ... time of the procedure, researchers found, with the odds being ... performing a hysterectomy with morcellation use a power cutter to ...
    (Date:7/22/2014)... French . ... to step out for a cigarette twice as often as ... those who have the hardest time shaking off the habit ... aware of. , Those insights were among the collective findings ... by a team of researchers based in part at ...
    (Date:7/22/2014)... 5i Sciences, a medical technology company focused ... Coye, M.D., M.P.H. to a role as Senior Consultant. ... the market introduction of innovative technologies that impact healthcare ... on strategies for building a successful commercial healthcare enterprise ... Coye is currently the Chief Innovation Officer of UCLA ...
    Breaking Medicine News(10 mins):Health News:ABC’s BLACK BOX Spotlights Mental Health and Available Resources in Upcoming Episode 2Health News:Botulinum Neurotoxins Marketplace Analysed in New La Merie Publishing Report Available at MarketPublishers.com 2Health News:Botulinum Neurotoxins Marketplace Analysed in New La Merie Publishing Report Available at MarketPublishers.com 3Health News:Botulinum Neurotoxins Marketplace Analysed in New La Merie Publishing Report Available at MarketPublishers.com 4Health News:Technique Used in Some Hysterectomies May Help Spread Cancer: Study 2Health News:Technique Used in Some Hysterectomies May Help Spread Cancer: Study 3Health News:Extra exercise helps depressed smokers kick the habit faster 2Health News:5i Sciences Announces Appointment of a Senior Healthcare Consultant and Successful Financing 2
    ... The Michael J. Fox,Foundation (MJFF) for Parkinson,s Research ... effort. Under this annual program the Foundation,will award ... designed to validate the,therapeutic potential of scientific discoveries, ... investment and clinical trials., "Target Validation is ...
    ... cells in the liver, allowing steatosis (simple fatty liver) ... to the results of a new study in the ... Wiley & Sons on behalf of the American Association ... is also available online at Wiley Interscience (http://www.interscience.wiley.com/journal/hepatology). , ...
    ... Carrington,Laboratories, Inc. (OTC Bulletin Board: CARN) today ... present,at the Acumen BioFin Rodman & Renshaw 9th ... pm Eastern Time at the New York Palace,Hotel. ... technologies in the,areas of drug delivery and vaccine ...
    ... NEW YORK, Nov. 1 Fibromyalgia is the ... States, affecting more than,six million Americans. But, findings ... Association (NFA) show there is still much to ... of the general public shows nearly half (45%) ...
    ... ... Services, DALLAS, Nov. 1 ... the largest gift in the,institution,s 80-year history. The Schenkels, gift today represents ... Schenkels, $4 million gift, the fund now tops the $50,million mark. ...
    ... is common in children with heart disease, a population ... , More than 25 percent of children with ... say researchers from The Childrens Hospital of Philadelphia and ... current issue of Pediatrics. While this 25 percent prevalence ...
    Cached Medicine News:Health News:Michael J. Fox Foundation Commits Up to $2 Million for PD Drug Development Under Target Validation 2008 2Health News:High-fat diet makes mice susceptible to liver injury 2Health News:Carrington Subsidiary DelSite to Present at Investor Conference 2Health News:Medialink Features: The Painful Truth About Fibromyalgia 2Health News:Methodist Health System Foundation Announces Largest Single Gift 2Health News:Methodist Health System Foundation Announces Largest Single Gift 3Health News:Methodist Health System Foundation Announces Largest Single Gift 4Health News:Obesity common in children with heart disease 2
    ... Flowmaster. It is a new portable digital flowmeter ... of use, simplicity and cost effectiveness are top ... now very easy to give a patient some ... and data will be send wirelessly to the ...
    ... the second generation of Urocap, ... zeroing, starting, stopping and printing. ... uroflowmetry parameters with superior low ... provides standard ICS nomenclature normative ...
    ... Uro-Guide Open Tip Ureteral ... silicone over-the-wire stents and ... design with an open ... of time-tested biocompatible silicone ...
    ... patient position during surgery is key to ... procedures. Not every patient is able to ... movements can compromise the procedure or necessitate ... Rousseau chin-lift stabilizer eliminates the "drifting that ...
    Medicine Products: